Former NFL pro Chris Maragos wins $43.5 million medical malpractice claim

Published Date: 02 Mar 2023

The legal team said the jury's decision could make medics think twice before allowing the injured to return to the field.

Read Full News

Latest News

Does ART Match ALND After Neoadjuvant Breast Cancer Therapy?

After neoadjuvant breast cancer treatment, axillary radiotherapy may offer an effective alternative to axillary lymph node dissection.

BC Rate Low in BRCA Carriers After Risk-Reducing Mastectomy

Researchers conduct a study of more than 1000 women with BRCA1 or BRCA2 mutations to compare breast cancer rates between those who do and do not undergo mastectomy.

Physalis minima (Golden Cherry)

Also known as golden cherry, Physalis minima is used often to treat inflammation, neurodegenerative disorders, and cancer in East Malaysian traditional medicine.

Should Doctors Strike to Limit AI Use at Work?

Some healthcare workers have been able to limit the role of AI in their work after going on strike. Is this a useful tactic for doctors?

Q&A: When Is It Safe to Skip Surgery for DCIS?

Active surveillance is gaining traction for women with low-risk DCIS, but key questions on patient selection and long-term safety remain.

Surveillance or Surgery for Low-Risk DCIS

Early findings suggest some women with low-risk DCIS may avoid immediate surgery, although investigators caution that longer follow-up is needed.

Todays Updates

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Infection Burden High With Myeloma T-Cell Therapies

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Todays Updates

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Infection Burden High With Myeloma T-Cell Therapies

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Latest News

After neoadjuvant breast cancer treatment, axillary radiotherapy may offer an effective alternative to axillary lymph node dissection.

Researchers conduct a study of more than 1000 women with BRCA1 or BRCA2 mutations to compare breast cancer rates between those who do and do not undergo mastectomy.

Also known as golden cherry, Physalis minima is used often to treat inflammation, neurodegenerative disorders, and cancer in East Malaysian traditional medicine.

Some healthcare workers have been able to limit the role of AI in their work after going on strike. Is this a useful tactic for doctors?

Active surveillance is gaining traction for women with low-risk DCIS, but key questions on patient selection and long-term safety remain.

Early findings suggest some women with low-risk DCIS may avoid immediate surgery, although investigators caution that longer follow-up is needed.

News All Time

Does ADT Improve Survival After PORT in Prostate Cancer?

A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.

Exercise and Lifestyle Help Manage Ankylosing Spondylitis

Evidence shows supervised exercise programs significantly improve function and quality of life in patients with axial spondyloarthritis.

Can Local Therapy Extend Life in Metastatic Breast Cancer?

For some women with de novo metastatic breast cancer, surgical resection of the primary tumor is associated with longer survival.

How to Talk to Your Patients About Exercise and Pain

Some are afraid to move if it hurts. Some push too hard. Everyone agrees that exercise reduces chronic pain and enhances health — but how do you keep patients on track?

CEM Matches MRI for Nipple-Areola Analysis in Breast Cancer

Contrast-enhanced mammography offers a reliable alternative to MRI in evaluating nipple-areola complex involvement in patients with breast cancer before surgery.

PSA May Predict Hormone Therapy Benefit Post-Prostatectomy

A meta-analysis seeks to determine if adding hormone therapy to radiotherapy after prostatectomy improves overall survival.

Life in the Endless Scroll: What We're Losing

What looks like harmless screen time may be altering emotional resilience and cognitive focus in young users.

Doc Pay Boosted $400 Million With New Medicare Billing Code

A new JAMA study shows that a new Medicare billing code may have benefited specialists more than the primary care physicians it was designed to help most.

MRI-Guided Chemotherapy Improves Survival in Breast Cancer

MRI-guided personalisation of neoadjuvant chemotherapy duration is associated with improved 3-year survival outcomes in patients with stage II-III HER2-positive breast cancer, a new trial reports.

NICE Backs Paperclip-Sized Sensor for Heart Failure Care

The CardioMEMS HF System enables daily home monitoring and has been shown to reduce hospital admissions in high-risk patients with chronic heart failure.

Dual Biologics May End Daily Pills Post-Kidney Transplant

A novel dual biologic regimen combining dazodalibep and belatacept is well tolerated and could enable more than half the kidney transplant recipients to avoid broader metabolic pathway inhibitors.

Which Imaging Method Best Detects At-Risk MASH?

Noninvasive imaging tests may help identify at-risk metabolic dysfunction-associated steatohepatitis, with a FibroScan-based scoring system performing best among commonly used methods.

FMT May Clear Drug Resistant Pseudomonas in Blood Cancer

Faecal microbiota transplantation appears to be effective in decolonising carbapenem-resistant Pseudomonas and is safe in patients with hematologic malignancies, a retrospective analysis shows.

Vaccination at All Ages Is Crucial and Safe, Says Ethicist

Ethicist Art Caplan discusses federal vaccine policy changes in the United States.

Physician Shortage: Give Nurses a Shot?

Abundant randomized trial data support using nurses instead of physicians in certain healthcare roles, but does that mean we should do it?

Heart Device Rivals Transplant Survival in Young HF Patients

Implantation of a left ventricular assist device offers survival outcomes similar to heart transplantation in young patients with advanced heart failure, a study finds.

Recommended News For You

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.

What Comes After Cancer?

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

Colon cancer and exercise: Can physical activity reprogram genes?

Recommended Articles For You

Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health 

Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon  

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

The Unseen Threat: Uncovering the Risks of Pancoast Tumor 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Recurrent UTIs impact eGFR in children with vesicoureteral reflux

2.

Inner Thoughts of Leonard Bernstein, the "Maestro".

3.

The need for more Latinx participants in Alzheimer's trials is urgent.

4.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

5.

BlurryScope: A compact, AI-powered microscope for rapid, cost-effective cancer scoring

1.

Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms

2.

Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy

3.

Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges

4.

The Complications and Treatments of Intraosseous Hemangioma - A Comprehensive Guide

5.

Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot